DWTX today
$1.19+$0.01 (+0.85%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourBearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $5.29
Key levels
Resistance$2.50
Resistance$1.62
Latest news & SEC filings
EarningsDogwood Therapeutics Reports Third Quarter 2026 Financial Results
SEC FilingDogwood Therapeutics, Inc. filed a report on a major company event (Form 8-K)
All DWTX news →About Dogwood Therapeutics
Dogwood Therapeutics is a clinical-stage biopharmaceutical company developing treatments for pain and neuropathy. Its lead candidate, Halneuron, is a non-opioid sodium channel modulator in late-stage testing for chemotherapy-induced neuropathic pain. The company also has an early-stage peptide program called SP16 and antiviral combination therapies for fibromyalgia and Long-COVID. It operates in the United States and Canada.
Based on the company's 10-K filed Mar 18, 2026.
Nasdaq · Healthcare
Dogwood Therapeutics, Inc. (DWTX)
What Is the Price Target for DWTX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is DWTX a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DWTX.
Start Free Trial →Is DWTX Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
12
Moat Score
NONE
2/9
Piotroski Score
-2.4
Altman Z-Score
What Is Smart Money Doing with DWTX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Sealbond Ltd | director 10% owner | Buy | 4,098,360 | $5.0M | Oct 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →DWTX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
43.05%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for DWTX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for DWTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:55:43 | $1.19 | 1,931 | $$2K | BUY |
| 16:36:11 | $1.17 | 2,725 | $$3K | BUY |
| 16:04:49 | $1.16 | 1,538 | $$2K | BUY |
| 14:45:30 | $1.20 | 3,126 | $$4K | BUY |
| 14:31:46 | $1.15 | 1,200 | $$1K | SELL |
5 dark pool trades shown · $$12K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Dogwood Therapeutics, Inc. (DWTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DWTX — frequently asked questions
What is DWTX stock price today?
Dogwood Therapeutics, Inc. (DWTX) is at $1.19, up 0.85% (+$0.01) at the Nov 12, 2026 close.
Why is DWTX stock moving today?
Latest DWTX news — Nov 5, 2026: Dogwood Therapeutics Reports Third Quarter 2026 Financial Results · Nov 5, 2026: Dogwood Therapeutics, Inc. filed a report on a major company event (Form 8-K)
Why did DWTX stock move on Oct 30, 2026?
Dogwood Therapeutics filed a shelf registration (Form S-3) and a prospectus covering 4.098 million common shares for resale by a selling stockholder, both signaling potential dilution. The stock closed at $1.29, down 0.38% on the day, trading between $1.28 and $1.35 on volume of 54,895 shares.
What do analysts rate DWTX?
Analyst ratings for DWTX: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did DWTX beat earnings?
DWTX last reported on Aug 13, 2026: EPS -$0.34 vs -$0.14 expected — a miss of 142.9%.
What is DWTX's P/E ratio?
DWTX trades at a P/E of 0.4 vs a Healthcare average of 18.5.
Does DWTX pay a dividend?
DWTX does not currently pay a dividend.
What are DWTX support and resistance levels?
Resistance: $1.62, $2.50, $2.72.
What are insiders doing with DWTX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on DWTX?
Nov 5, 2026: Dogwood Therapeutics Reports Third Quarter 2026 Financial Results · Nov 5, 2026: Dogwood Therapeutics, Inc. filed a report on a major company event (Form 8-K)